Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Concentrix Reports Fourth Quarter and Fiscal Year 2024 Results

In This Article:

Concentrix Solutions Corporation
Concentrix Solutions Corporation
  • Delivers revenue growth at the high end of previous guidance range for the quarter

  • Returns $220 million to shareholders in fiscal 2024 through share repurchases and dividends

  • Gains market traction with new iX GenAI productivity applications

  • Introduces 2025 guidance indicating revenue growth, margin and free cash flow expansion

  • Increases share repurchase authorization to $600 million

NEWARK, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal fourth quarter and fiscal year ended November 30, 2024.

 

Three Months Ended

 

 

 

Fiscal Year Ended

 

 

 

November 30, 2024

 

November 30, 2023

 

Change

 

November 30, 2024

 

November 30, 2023

 

Change

Revenue ($M)

$

2,448.0

 

 

$

2,230.8

 

 

9.7

%

 

$

9,618.9

 

 

$

7,114.7

 

 

35.2

%

Operating income ($M)

$

144.5

 

 

$

180.4

 

 

(19.9

)%

 

$

596.4

 

 

$

661.3

 

 

(9.8

)%

Non-GAAP operating income ($M) (1)

$

346.7

 

 

$

340.8

 

 

1.7

%

 

$

1,317.9

 

 

$

1,010.0

 

 

30.5

%

Operating margin

 

5.9

%

 

 

8.1

%

 

-220 bps

 

 

6.2

%

 

 

9.3

%

 

-310 bps

Non-GAAP operating margin (1)

 

14.2

%

 

 

15.3

%

 

-110 bps

 

 

13.7

%

 

 

14.2

%

 

-50 bps

Net income ($M)

$

115.7

 

 

$

69.5

 

 

66.5

%

 

$

251.2

 

 

$

313.8

 

 

(19.9

)%

Non-GAAP net income ($M) (1)

$

219.3

 

 

$

213.5

 

 

2.7

%

 

$

772.3

 

 

$

630.7

 

 

22.5

%

Adjusted EBITDA ($M) (1)

$

402.9

 

 

$

397.9

 

 

1.3

%

 

$

1,554.9

 

 

$

1,181.8

 

 

31.6

%

Adjusted EBITDA margin (1)

 

16.5

%

 

 

17.8

%

 

-130 bps

 

 

16.2

%

 

 

16.6

%

 

-40 bps

Diluted earnings per common share

$

1.72

 

 

$

1.09

 

 

57.8

%

 

$

3.71

 

 

$

5.70

 

 

(34.9

)%

Non-GAAP diluted earnings per common share (1)

$

3.26

 

 

$

3.36

 

 

(3.0

)%

 

$

11.42

 

 

$

11.45

 

 

(0.3

)%

(1) See non-GAAP reconciliations included in the accompanying financial tables for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure.

Fourth Quarter Fiscal 2024 Highlights:

  • Revenue of $2,448.0 million, an increase of 9.7% year-on-year compared to revenue of $2,230.8 million in the prior year fourth quarter. The Company grew revenue by 1.5% year-on-year on a pro forma constant currency basis, at the top end of its guidance range previously provided.

  • Operating income of $144.5 million, or 5.9% of revenue, compared with $180.4 million, or 8.1% of revenue in the prior year fourth quarter.

  • Non-GAAP operating income of $346.7 million, or 14.2% of revenue, compared with $340.8 million, or 15.3% of revenue, in the prior year fourth quarter. The change in non-GAAP operating margin was primarily due to spending related to the productization and commercialization of the Company’s new GenAI iX product suite.

  • Adjusted EBITDA of $402.9 million, or 16.5% of revenue, compared with $397.9 million, or 17.8% of revenue, in the prior year fourth quarter.

  • Cash flow from operations was $284.4 million in the quarter. Adjusted free cash flow for the quarter was $218.7 million.

  • Diluted earnings per common share (“EPS”) was $1.72 compared to $1.09 in the prior year fourth quarter.

  • Non-GAAP diluted EPS was $3.26 compared to $3.36 in the prior year fourth quarter.